MicroPort is a multinational medical technology company with headquarters in Shanghai; Irvine, California; and Clamart, France. The company designs and produces medical devices across multiple therapeutic areas including interventional cardiology, orthopedics, cardiac rhythm management, electrophysiology, neurovascular intervention, structural heart disease, surgical robotics, and critical care. MicroPort completed its initial public offering on the Hong Kong Stock Exchange in 2010 and has since established multiple specialized subsidiaries focused on distinct therapeutic areas, with several completing separate public listings. Recognized as one of the global Medtech Big 100 companies, MicroPort's coronary intervention products have been implanted in over 10 million patients globally since its founding, with devices distributed globally in over 90 countries across. Wikipedia